Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study

@article{Davis2004SilentMI,
  title={Silent myocardial infarction and its prognosis in a community-based cohort of Type 2 diabetic patients: the Fremantle Diabetes Study},
  author={Timothy M. E. Davis and Paul J. Fortun and J. M. Mulder and Wendy A Davis and David G. Bruce},
  journal={Diabetologia},
  year={2004},
  volume={47},
  pages={395-399}
}
Aims/hypothesisOur study investigated the prognosis of Type 2 diabetic patients with silent myocardial infarction in a community-based cohort.MethodsWe analysed data from 1269 patients with Type 2 diabetes mellitus from a community-based observational study of diabetes care, control and complications. Silent myocardial infarction was defined as Q waves (Minnesota codes 1.1, 1.2) on a baseline electrocardiogram in the absence of a history or symptoms of CHD.ResultsSilent myocardial infarction… 
Electrocardiography-defined silent CHD and risk of cardiovascular events among diabetic patients in a Middle Eastern population
TLDR
In both sexes, symptomatic CHD was an independent predictor of recurrent CVD/CHD, regardless of ECG results, which provides evidence-based support only in men for the ADA recommendation of ‘further cardiac testing for diabetic patients with an abnormal resting ECG’.
Prognostic Significance of Silent Myocardial Infarction in Newly Diagnosed Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79
TLDR
About 1 in 6 UKPDS patients with newly diagnosed type 2 diabetes mellitus had evidence of silent myocardial infarction, which was independently associated with an increased risk of fatal MI and all-cause mortality, however, identification of SMI does not add substantively to current UKP DS Risk Engine predictive variables.
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
TLDR
Fenofibrate reduces therisk of a first MI and substantially reduces the risk of further clinical CVD events after silent MI, supporting its use in type 2 diabetes.
Incidence and Prevalence of Unrecognized Myocardial Infarction in People With Diabetes
TLDR
Although the prevalence and incidence of myocardial infarction was low, unrecognized Q-wave myocardia infarctions made up a substantial proportion of all events.
Silent myocardial infarction in women with type II diabetes mellitus and microalbuminuria
TLDR
Clinically significant proportion of the women with DM and albuminuria without previous history of ischemic heart disease and normal electrocardiogram suggesting the presence of IHD have had silent myocardial infarction.
SILENT ISCHEMIA IN TYPE I DIABETIC PATIENTS: A STUDY OF EKG CHANGES
INTRODUCTION: Ischemic Heart Diseases (IHD) is the major cause of mortality and morbidity worldwide. Diabetes Mellitus (DM) is known as one of the main risk factors of IHD. Silent ischemia is seen in
Does Silent Myocardial Ischemia based on Resting Electrocardiogram Criteria Predict Cardiovascular Mortality in Older Adults with and without diabetes : A 23 Year Prospective Study.
TLDR
Silent MI identified by resting ECG remains an important predictor of CVD mortality regardless of other risk factors in those without diabetes.
ISCHEMIA IN TYPE I DIABETIC PATIENTS : A STUDY OF EKG CHANGES Abstract
INTRODUCTION: Ischemic Heart Diseases (IHD) is the major cause of mortality and morbidity worldwide. Diabetes Mellitus (DM) is known as one of the main risk factors of IHD. Silent ischemia is seen in
Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study
TLDR
Race and sex differences in the incidence and prognostic significance of SMI exist that may warrant considering SMI in personalized assessments of coronary heart disease risk and are associated with poor prognosis.
...
...

References

SHOWING 1-10 OF 11 REFERENCES
Silent myocardial ischemia in patients with diabetes: who to screen.
TLDR
Routine screening is recommended for male patients in whom the duration of type 2 diabetes is >10 years or even less when more than one cardiovascular risk factor is present, and a high-risk group for SMI in the diabetic population is determined.
Resting electrocardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population.
The prevalence of ischemic heart disease (IHD) in older adults by glucose tolerance status was evaluated in 2,223 white men and women, aged 50-89 years, in the Rancho Bernardo cohort who were studied
Unrecognized myocardial infarction: five-year incidence, mortality, and risk factors.
TLDR
A multivariate analysis showed that the most significant risk factors were age, left axis deviation, left ventricular hypertrophy, cigarette smoking, systolic or diastolic blood pressure, and peripheral vascular disease.
The incidence and prognosis of unrecognized myocardial infarction in the Honolulu, Hawaii, Heart Program.
TLDR
It is suggested that regular health check-ups with an electrocardiogram would be important to detect asymptomatic myocardial infarction and to increase the opportunity of taking secondary preventive measures.
Silent coronary artery disease in diabetes – a feature of autonomic neuropathy or accelerated atherosclerosis?
TLDR
There is no convincing clinical or epidemiological evidence that diabetic autonomic neuropathy plays a major part in the lack of ischaemic pain, and the mechanisms of silent myocardial ischaemia are complex and controversial even without diabetes.
An evidence-based review of the resting electrocardiogram as a screening technique for heart disease.
TLDR
The sensitivity of the ECG for future events was too low for it to be practical as a screening tool and a serious goal for the medical industry should be to end the morass of proprietary ECG digital formats and follow a standardized format.
Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi‐ethnic Australian community: the Fremantle Diabetes Study
SUMMARY
Unrecognized myocardial infarction and hypertension: the Framingham Study.
Cardiovascular survey methods.
...
...